INS and type 2 diabetes mellitus: This study first demonstrated that T2D patients with higher adiponectin levels (6.2 μg/mL or greater) had older age, higher systolic blood pressure, lower eGFR, as well as lower BMI, HbA1c, insulin resistance indices, and C-reactive protein, than those with lower adiponectin levels.